Global Blood Glucose Testing Equipment Market Size By Type (Desktop, Portable), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Blood Glucose Testing Equipment Market was valued at USD 15.6 billion in 2023 and is projected to reach USD 27.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. The market’s robust growth is fueled by the increasing prevalence of diabetes worldwide, heightened awareness of preventive healthcare, and technological advancements in self-monitoring blood glucose (SMBG) devices. The rapid adoption of portable and continuous glucose monitoring (CGM) devices further accelerates market momentum, offering users greater convenience, accuracy, and real-time insights into glucose levels.

Drivers

Rising Prevalence of Diabetes:

The global burden of diabetes continues to surge due to sedentary lifestyles, unhealthy diets, and aging populations. This rise directly propels the demand for reliable and accessible blood glucose testing equipment.

Technological Advancements in Monitoring Devices:

Innovations such as CGM systems, wearable biosensors, and smartphone-integrated glucometers are transforming diabetes care by enabling continuous and accurate glucose tracking, supporting both patients and healthcare providers.

Increased Health Awareness and Preventive Care:

Public health initiatives and campaigns are fostering awareness of early diagnosis and blood sugar control, driving adoption of home-based glucose testing devices among both diabetic and prediabetic populations.

Restraints

High Cost of Advanced Devices:

While modern CGMs and smart glucometers offer superior performance, their high price points and recurring sensor replacement costs can hinder adoption, particularly in low- and middle-income economies.

Regulatory Hurdles and Product Recalls:

Stringent regulatory frameworks for device approvals and occasional product recalls due to safety concerns can delay product availability and erode consumer confidence.

Opportunity

Untapped Potential in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are witnessing rising diabetes prevalence. With growing healthcare investments and awareness, these regions present lucrative opportunities for market expansion.

Integration of AI and IoT in Glucose Monitoring:

The convergence of artificial intelligence, Internet of Things (IoT), and data analytics is opening new frontiers in blood glucose monitoring, enabling predictive insights, personalized alerts, and remote healthcare monitoring capabilities.

Market by System Type Insights

The Self-Monitoring Blood Glucose (SMBG) segment held the largest share in 2023, attributed to its affordability, ease of use, and strong penetration in home healthcare settings. However, the Continuous Glucose Monitoring (CGM) segment is expected to witness the fastest growth through 2031, driven by its ability to provide real-time data and improved glycemic control for Type 1 and Type 2 diabetes patients alike.

Market by End-use Insights

Hospitals & Clinics emerged as the leading end-use segment in 2023, fueled by high patient footfall and the need for accurate diagnostics. Meanwhile, the home care segment is expected to register remarkable growth, reflecting the global shift toward patient-centric, home-based care supported by compact, user-friendly monitoring tools.

Market by Regional Insights

North America dominated the global market in 2023, owing to a high diabetic population, well-developed healthcare infrastructure, and favorable reimbursement scenarios. However, Asia-Pacific is poised to experience the highest CAGR during the forecast period, supported by increasing healthcare expenditure, improving access to medical devices, and growing awareness of diabetes management in countries like India and China.

Competitive Scenario

Major players in the global blood glucose testing equipment market include Abbott Laboratories, F. Hoffmann-La Roche AG, Medtronic plc, Dexcom Inc., Ascensia Diabetes Care, LifeScan Inc., B. Braun Melsungen AG, Terumo Corporation, ARKRAY Inc., and Sinocare Inc. These companies are focusing on expanding product portfolios, AI integration, strategic partnerships, and regional expansion to capture a larger share of the growing market.

Recent developments include:

In 2024, Abbott Laboratories launched a next-gen CGM device with 15-day wearability and Bluetooth connectivity, improving user compliance.

Dexcom Inc. received regulatory approval in 2023 for its real-time CGM system tailored for pediatric use in Europe.

Medtronic announced a partnership in 2023 with a major telehealth provider to integrate CGM data with virtual diabetes care platforms.

Scope of Work – Global Blood Glucose Testing Equipment Market

Report Metric Details

Market Size (2023) USD 15.6 Billion

Projected Market Size (2031) USD 27.1 Billion

CAGR (2023–2031) 7.3%

Market Segments By System Type, End-use, Region

Growth Drivers Rising diabetes prevalence, tech innovation, preventive care awareness

Opportunities AI & IoT integration, Emerging markets expansion

Key Market Developments

2024: Abbott Laboratories launched Libre 4 CGM with longer battery life and smartphone-only interface.

2023: Dexcom Inc. expanded its operations in India and Southeast Asia with localized versions of its G7 system.

2023: LifeScan announced a partnership with Fitbit to integrate blood glucose data with wearable fitness analytics.

FAQs

1) What is the current market size of the Global Blood Glucose Testing Equipment Market?

The market size in 2023 was valued at USD 15.6 billion.

2) What is the major growth driver of the Global Blood Glucose Testing Equipment Market?

The rising global prevalence of diabetes and the adoption of smart, connected monitoring devices are major growth drivers.

3) Which is the largest region during the forecast period in the Global Blood Glucose Testing Equipment Market?

North America leads the market, while Asia-Pacific is projected to grow at the fastest rate.

4) Which segment accounted for the largest market share in the Global Blood Glucose Testing Equipment Market?

The Self-Monitoring Blood Glucose (SMBG) segment held the largest share in 2023.

5) Who are the key market players in the Global Blood Glucose Testing Equipment Market?

Key players include Abbott Laboratories, Roche, Dexcom, Medtronic, LifeScan, and Ascensia Diabetes Care.